What insulin resistance actually means

Insulin is a hormone produced by the pancreatic beta cells in response to rising blood glucose, primarily after eating. Its role is to signal cells throughout the body to take up glucose from the bloodstream for energy or storage. In a healthy metabolic state, a small amount of insulin produces a large and rapid cellular response: blood glucose rises, insulin is released, cells respond, glucose is cleared, and insulin returns to baseline.

Insulin resistance describes the state in which this cellular response has become blunted, cells no longer respond efficiently to the insulin signal, requiring more and more insulin to achieve the same glucose clearance. The pancreas compensates by producing progressively larger amounts of insulin, and this compensated hyperinsulinaemia is the state in which most metabolic disease develops, long before blood sugar rises into the diabetic range.

"By the time blood sugar rises on a fasting test, insulin resistance has typically been established for 10–15 years. The damage begins long before the diagnosis."

How insulin resistance develops

Insulin resistance is primarily a dietary and lifestyle condition, though genetic predisposition determines how quickly it develops in a given environment. The foundational mechanism is cellular lipid overload: when cells, particularly liver cells and muscle cells, accumulate excess fat from dietary or endogenous sources, they develop molecular interference in the insulin signalling pathway. The insulin receptor is activated, but the downstream cascade that should transport glucose into the cell is blocked by accumulated diacylglycerol and ceramide molecules.

The dietary drivers that produce cellular lipid overload are: excess refined carbohydrates and fructose that directly promote hepatic (liver) fat accumulation through de novo lipogenesis; excess caloric intake that overwhelms cellular storage capacity; and inadequate physical activity that reduces the rate at which cells clear their lipid content through oxidative metabolism. Chronic stress, sleep disruption, and gut dysbiosis each worsen insulin resistance through independent mechanisms.

🌾
Refined carbohydrates and fructose
Refined carbohydrates produce rapid, high-amplitude blood glucose spikes requiring large insulin responses. Repeated high-amplitude spikes progressively deplete insulin receptor sensitivity. Fructose, present in sugar, sweetened beverages, and ultra-processed foods, is preferentially metabolised in the liver as fat, directly producing hepatic insulin resistance.
🛋️
Physical inactivity
Skeletal muscle is the primary site of glucose disposal, accounting for approximately 70% of insulin-mediated glucose uptake. Inactivity reduces the density of glucose transporters in muscle cells and allows lipid accumulation that directly interferes with insulin signalling.
😰
Chronic stress
Cortisol directly promotes insulin resistance through two mechanisms: it stimulates hepatic glucose production (raising blood sugar independently of food) and it reduces peripheral insulin receptor sensitivity. Chronic cortisol elevation from sustained stress produces insulin resistance that worsens with stress duration.
🦠
Gut dysbiosis
The gut microbiome modulates insulin sensitivity through multiple pathways, SCFA production, LPS-driven inflammation, and bile acid metabolism. Gut dysbiosis worsens insulin resistance, and gut restoration helps improve it, independently of dietary change.
😴
Sleep disruption
Even a single week of partial sleep restriction produces measurable insulin resistance in healthy volunteers. Sleep deprivation reduces glucose uptake in muscle and brain, elevates cortisol, and increases ghrelin (appetite hormone), creating a hormonal environment that promotes fat storage and impairs glucose metabolism.

What insulin resistance produces

Chronically elevated insulin, the compensatory response to insulin resistance, is independently damaging across multiple systems, beyond its role in blood sugar regulation:

In the ovaries, elevated insulin stimulates androgen production in the theca cells and suppresses sex hormone binding globulin (SHBG), producing the androgen excess of PCOS, irregular ovulation, acne, and scalp hair loss. Insulin resistance is the foundational mechanism of PCOS in the majority of patients.

In the liver, insulin resistance promotes fat accumulation and impairs fat oxidation, producing non-alcoholic fatty liver disease (NAFLD). The liver continues to produce glucose even when blood sugar is already elevated (hepatic insulin resistance), directly worsening glycaemic control.

In the cardiovascular system, elevated insulin promotes sodium retention (raising blood pressure), stimulates vascular smooth muscle growth (increasing arterial stiffness), elevates triglycerides and reduces HDL (the characteristic dyslipidaemia of insulin resistance), and promotes endothelial dysfunction.

In the brain, insulin resistance impairs neuronal glucose uptake, producing the cognitive impairment, brain fog, and afternoon energy crashes of metabolic dysfunction. Insulin signalling in the brain regulates memory consolidation and cognitive function; its impairment is increasingly linked to neurodegenerative disease risk.

In the adrenal glands, elevated insulin stimulates adrenal androgen production, contributing to acne, hair loss, and the masculinising features that accompany PCOS and metabolic obesity in women.

Type 2 Diabetes
→
Prediabetes
→
PCOS / PCOD
→
Fatty Liver
→
Metabolic Syndrome
→
Hypertension
→
Obesity with IR
→
Brain Fog
→

How insulin resistance is measured

Fasting glucose and HbA1c, the standard metabolic tests, detect insulin resistance only after the pancreatic compensation has begun to fail. A normal HbA1c does not exclude insulin resistance. Fasting insulin, measured alongside fasting glucose, allows calculation of HOMA-IR (Homeostatic Model Assessment of Insulin Resistance), which identifies insulin resistance in the compensated phase, years before blood sugar rises.

A fasting insulin above 10 μIU/mL with a normal fasting glucose is a direct indicator of insulin resistance. A HOMA-IR above 1.9 is considered borderline; above 2.9 indicates significant insulin resistance. These thresholds are rarely applied in routine blood testing, which is why insulin resistance is diagnosed late, if at all.

Key Concept
The compensation window
The decade or more during which the pancreas produces compensatory hyperinsulinaemia to maintain normal blood sugar is the optimal intervention window. Correcting insulin resistance during this phase is significantly more effective than after the pancreas has lost its compensatory capacity and blood sugar begins to rise. This is why fasting insulin is the most clinically important metabolic marker to assess, not fasting glucose alone.

How CLCC corrects insulin resistance

Dietary structure is the primary intervention. A low-insulin dietary protocol, reducing refined carbohydrates and fructose, increasing fibre, protein, and healthy fats, and structuring meal timing to allow adequate inter-meal insulin recovery, produces measurable reduction in fasting insulin within 2–4 weeks. This is not caloric restriction; it is insulin demand management.

Gut restoration independently improves insulin sensitivity through SCFA production and reduction of LPS-driven inflammatory interference in insulin signalling.

Physical activity, particularly resistance exercise and post-meal walking, increases GLUT4 transporter density in muscle cells, directly improving glucose uptake capacity independently of insulin.

Sleep correction and stress load reduction address the cortisol-driven and sleep-disruption-driven components of insulin resistance that dietary change alone cannot fully resolve.

Targeted supplementation, berberine, chromium, inositol (in PCOS), alpha-lipoic acid, provides additional insulin sensitisation where clinically indicated. These are adjuncts to dietary correction, not substitutes.